dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Bazzocco, Sarah |
dc.contributor.author | Dopeso Gonzalez, J Higinio |
dc.contributor.author | Martinez Barriocanal, Agueda |
dc.contributor.author | Li, Jing |
dc.contributor.author | Garcia Vidal, Elia Maria |
dc.contributor.author | Maggio, Valentina |
dc.contributor.author | Gonçalves Rodrigues, Paulo Andre |
dc.contributor.author | Guimaraes De Marcondes, Priscila |
dc.contributor.author | Schwartz Navarro, Simon |
dc.contributor.author | Arango Corro, Diego |
dc.contributor.author | Anguita Espinosa, Estefanía |
dc.contributor.author | Nieto Raya, Rocio |
dc.date.accessioned | 2022-04-05T08:43:08Z |
dc.date.available | 2022-04-05T08:43:08Z |
dc.date.issued | 2021-04-23 |
dc.identifier.citation | Bazzocco S, Dopeso H, Martínez-Barriocanal Á, Anguita E, Nieto R, Li J, et al. Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome ‑ wide promoter hypermethylation analysis. Clin Epigenetics. 2021 Apr 23;13:88. |
dc.identifier.issn | 1868-7083 |
dc.identifier.uri | https://hdl.handle.net/11351/7298 |
dc.description | Càncer colorectal; Metilació; Dit de zinc |
dc.description.sponsorship | This study was partially funded by grants of the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF; PI16/00540, PI19/00993, AC20/00022 and AC15/00066) and the Spanish Association Against Cancer (AECC GCA15152966ARAN) to Diego Arango. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Clinical Epigenetics;13 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer - Aspectes genètics |
dc.subject | Recte - Càncer - Aspectes genètics |
dc.subject | ADN - Metilació |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | /genetics |
dc.subject.mesh | DNA Methylation |
dc.subject.mesh | Genes, Tumor Suppressor |
dc.title | Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s13148-021-01070-0 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | /genética |
dc.subject.decs | metilación del ADN |
dc.subject.decs | genes supresores de tumores |
dc.relation.publishversion | https://doi.org/10.1186/s13148-021-01070-0 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Bazzocco S, Dopeso H, Anguita E, Nieto R, Li J, García-Vidal E, Maggio V, Rodrigues P, de Marcondes PG] Grup d'Investigació Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Martínez-Barriocanal Á, Arango D] Grup d'Investigació Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Group of Molecular Oncology, IRBLleida, Lleida, Spain. [Schwartz S Jr] Grup de Lliurament i Orientació de Medicaments, CIBBIM Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra Spain. CIBER de Bioingeniería, Biomateriales Y Nanomedicina (CIBER-BBN), Madrid, Spain |
dc.identifier.pmid | 33892786 |
dc.identifier.wos | 000642915900001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00540 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |